Senior Director, Integrated Planning & Analytics - Global Supply Chain

About the role

The Senior Director, Integrated Planning & Analytics, leads enterprise planning across demand, supply, inventory, capacity, and financial objectives through Integrated Business Planning (IBP). This role drives profitable growth, operational agility, and patient-centric outcomes across a global rare disease supply network by connecting decisions across Commercial, Clinical, Manufacturing, Quality, Regulatory, Medical Affairs, and Finance.

Responsibilities

• Own the global IBP framework for rare disease planning, addressing demand variability, small batches, long lead times, and constrained capacity.
• Establish and maintain a consistent IBP cadence (Product Review, Demand Review, Supply Review, Integrated Reconciliation, Executive IBP).
• Own the S&OE (Sales & Operations Execution) process, ensuring near-term demand, supply, and inventory decisions are aligned to the broader IBP framework and escalated appropriately.
• Embed patient-centric planning principles into the IBP cycle (e.g., emergency orders, compassionate use, urgent clinical supply requests).
• Ensure seamless integration of clinical and commercial planning due to overlapping supply sources and shared manufacturing assets.
• Rare Disease Demand, Supply & Inventory Integration:
• Oversee reconciliation of commercial, patient, named-patient, early-access, and clinical trial demand signals.
• Ensure supply plans reflect long cycle times, yield variability, cold-chain requirements, and CMO dependencies.
• Lead Inventory Management to define inventory policies, targets, and positioning strategies that minimize expiry while guaranteeing immediate patient access for ultra-low-volume therapies.
• Lead risk-based scenario planning for demand surges (e.g., new diagnoses, outbreaks, compassionate use clusters), supply disruptions, or single-source component issues.
• Cross-Functional Leadership & Governance:
• Chair IBP forums across Commercial, Clinical Operations, Technical Operations, Manufacturing, Quality, Regulatory, Finance, and Medical.
• Establish governance and decision rights for trade-offs such as allocation priorities, safety stock strategies, and launch readiness.
• Lead structured decision-making in Executive IBP, ensuring senior leaders have clear scenarios, risks, and recommendations.
• Drive alignment across global, regional, and country planning, accounting for reimbursement and access variability.
• People Leadership:
• Lead the team of Integrating Planning & Analytics professionals, through strong development and mentoring while creating a culture of high accountability and innovation.
• Create departmental performance goals and objectives that the team of integrated planners can leverage to develop their respective objectives and provide performance feedback related to business objectives.
• Create a training curriculum to support Integrated Planning & Analytics Team’s development responsibilities.
• Influence teams across the supply chain planning organization to improve their maturity and collaboration through a harmonized integrated planning playbook maximizing optimal support to the planning cycles.
• Financial & Portfolio Integration:
• Partner closely with Finance, particularly during AOP/LRP cycles, to embed operational, revenue, COGS, and margin considerations into IBP.
• Support business case development for strategic investments (redundant capacity, alternate sites, new technology platforms) and lead long-range capacity planning/modeling to ensure the network can support future portfolio growth, new indications, and evolving patient demand.
• Data, Systems & Analytics:
• Define the IBP technology vision with Digital/IT, including platforms for complex, low-volume, high-variability planning.
• Ensure data quality for critical demand, therapy, batch, expiry, and distribution attributes.
• Lead Data Analytics to develop advanced planning insights, improve forecast ability of ultra-small populations, and evaluate risk-based scenarios for proactive decision-making.
• Stakeholder Engagement & Change Leadership:
• Drive adoption of IBP behaviors in a highly cross-functional, mission-driven rare disease culture.
• Communicate clearly with senior leadership on risks, trade-offs, and opportunities, always emphasizing patient impact.
• Build planning capability across global and regional teams and mentor planners supporting rare disease products.
• Function as an internal expert and thought leader on best-practice IBP/S&OP for rare disease and biologics.

Qualifications

• Bachelor’s degree in Supply Chain, Engineering, Business, Life Sciences, or related field.
• 12+ years of progressive supply chain or operations leadership in biotech, pharmaceutical, or rare disease environments.
• Proven leadership of global S&OP/IBP processes, including long-range capacity planning, inventory strategy, and executive decision support.
• Strong command of ERP, advanced planning systems, and analytics tools that support scenario modeling and business decisions.
• Deep understanding of life science supply chains, including access variability, long lead times, biologics complexity, and patient-critical supply continuity.
• Strong financial acumen with proven cross-functional leadership in matrixed organizations.
• Preferred Master’s degree (MBA, MS, or equivalent).
• Experience with biologics, gene therapy, enzyme replacement therapies, or other complex rare disease modalities.
• APICS/ASCM, SCOR-P, or equivalent certification.
• Experience integrating clinical and commercial supply processes.
• Familiarity with global regulatory / GxP constraints uniquely impacting rare disease therapies.

Core Competencies

• Patient-Centric Mindset — prioritizes therapy availability for individuals with life-altering conditions.
• Strategic Systems Thinking — understands complex network interactions across clinical and commercial supply, including long-range capacity and inventory trade-offs.
• Executive Influence — builds alignment, shapes decisions, and leads cross-functional forums with credibility in complex matrix environments.
• Data Analytics & Financial Acumen — translates operational scenarios into financial and patient impacts using data-driven insights and advanced planning analytics.
• Inventory Strategy — balances service, waste, and working capital through thoughtful inventory policy, positioning, and risk management.
• Risk Management — proactive identification and mitigation of rare disease supply vulnerabilities.
• Change Leadership — able to embed new planning behaviors, tools, and processes in a global organization.